Sartorius has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals, headquartered in Newark, Delaware, USA. The Institute, launched in 2017, is a public-private partnership and has an extensive network of academic and industry partners within the United States. Among the 115 associated members are 71 academic institutions, research laboratories, non-profit organizations and 44 companies – ranging from startups, small, medium and large companies. In addition...